Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Shareholders' Equity

v3.24.1.1.u2
Consolidated Statements of Changes in Shareholders' Equity
Number of common shares
CAD ($)
shares
Share capital
USD ($)
shares
Reserves
USD ($)
Obligation to issue shares
USD ($)
Accumulated Deficit
USD ($)
Accumulated other comprehensive (loss) income
USD ($)
USD ($)
Beginning balance, value at Dec. 31, 2020 $ 768,302   $ 758,296 $ 24,746 $ (6,398,686) $ (74,924) $ 986,654
Beginning balance, Share at Dec. 31, 2020 | shares   6,677,222          
Statement              
Reclassification of derivative warrant liability     (3,506,565)       (3,506,565)
Shares issued pursuant to private placement   $ 573,935         573,935
Shares issued pursuant to private placement (shares) | shares 231,743            
Shares issued pursuant to public listing   7,467,772         7,467,772
Shares issued pursuant to public listing (in shares) | shares 362,333            
Share issuance costs   (1,104,238) 405,659       (698,579)
Options exercised   118,285 (51,783)       66,502
Options exercised (in shares) | shares 5,678            
Pre-funded warrants exercised   2,296,609 (23,566)       2,273,043
Warrants exercised (in shares) | shares 72,398            
Share-based payments     396,423       396,423
Shares issued for services   59,092         59,092
Shares issued for services (in shares) | shares 2,839            
Net losses for the year             (1,579,274)
Comprehensive loss (income) for the year         (1,579,274) 150,464 (1,428,810)
Ending balance, Value at Dec. 31, 2021   16,088,677 4,991,594 24,746 (7,977,960) 75,540 13,202,597
Ending balance, Share at Dec. 31, 2021 | shares 1,443,293            
Statement              
Shares issued pursuant to public offering   359,868         359,868
Shares issued pursuant to public offering (shares) | shares 155,555            
Share issuance costs   (88,959) (42,687)       (131,646)
Pre-funded warrants exercised   (164,768) 164,704       (64)
Pre-funded warrants exercised (in shares) | shares 71,223            
Share-based payments     487,940       487,940
Net losses for the year             (7,718,882)
Pre-funded warrants issued     925,015       925,015
Comprehensive loss (income) for the year         (7,718,882) (128,145) (7,847,027)
Ending balance, Value at Dec. 31, 2022   16,524,354 6,197,158 24,746 (15,696,842) (52,605) 6,996,811
Ending balance, Share at Dec. 31, 2022 | shares 1,670,071            
Statement              
Reclassification of derivative warrant liability     (318,000)       (318,000)
Pre-funded warrants exercised   532,181 (531,885)       296
Pre-funded warrants exercised (in shares) | shares 328,777            
Share-based payments     (120,984)       (120,984)
Net losses for the year             (2,158,065)
Comprehensive loss (income) for the year         (2,158,065)   (2,158,065)
Ending balance, Value at Dec. 31, 2023   $ 17,056,535 $ 5,468,257 $ 24,746 $ (17,854,907) $ (52,605) $ 4,642,026
Ending balance, Share at Dec. 31, 2023 | shares 1,998,848